Riskpilot← Back to searchSign inGet full accessHeiMed Oy
OYDissolvedY-tunnus 3247196-6Runeberginkatu 49-A8Medical specialists activities · NACE 8622Est. 2021— employees
Revenue 2025
EUR 181K
0% vs 2024
EBITDA margin
-9.7%
-105% vs 2024
Equity ratio
28.8%
Financial strength
Net profit 2025
EUR -38K
-1194% vs 2024
| Revenue | EUR 181K | +0% |
| EBITDA | EUR -18K | -105% |
| Net profit | EUR -38K | -1194% |
| Total assets | EUR 106K | -26% |
| Equity | EUR 31K | -59% |
| Employees | — | — |
Legal name
HeiMed Oy
Y-tunnus number
3247196-6
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
9. marraskuuta 2021
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Erikoislääkäripalvelujen tuottaminen potilaille, alan koulutus- ja konsultointipalvelujen tuottaminen sekä kustannustoiminta.Yhtiö voi omistaa, hallita ja vuokrata kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Runeberginkatu 49-A8
Phone
+3580503866221
Email
juha.heino@mehilainen.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 368 | 370 | 181 | 181 |
| Staff expenses | −157 | 199 | 67 | −115 |
| EBITDA | 89 | 720 | 340 | −18 |
| Depreciation & amort. | −9 | — | 17 | −18 |
| EBIT | 81 | 26 | 6 | −36 |
| Net financials | −1 | −3 | — | — |
| Profit before tax | 79 | 23 | 4 | −38 |
| Tax | 16 | 5 | 1 | −0 |
| Net profit | 64 | 18 | 3 | −38 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 153 | 132 | 143 | 106 |
| Equity | 64 | 77 | 74 | 31 |
| Long-term debt | — | 45 | 56 | 63 |
| Short-term debt | 90 | 10 | 13 | 13 |
| Total debt | 90 | 55 | 69 | 76 |
EBITDA margin
-9.7%
This company
15.8%
Market median
-161% vs market
20222025
Equity ratio
28.8%
This company
38.2%
Market median
-25% vs market
20222025
Return on equity
-122.9%
This company
18.4%
Market median
-768% vs market
20222025
Net profit margin
-20.8%
This company
8.1%
Market median
-357% vs market
20222025
Asset turnover
1.70×
This company
1.12×
Market median
+52% vs market
20222025
Debt / equity
2.47×
This company
0.62×
Market median
-298% vs market
20222025
- Annual report 2025Filed via PRH / YTJ · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-11-01 – 2022-11-30
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
KJ Deputy Member | Deputy Member | 2021 |
JA Deputy auditor | Deputy auditor | 2024 |
JK Chief Executive Officer | Chief Executive Officer | 2021 |
KK Audit | Audit | 2024 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HeiMed Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kai Juhani Laamanen | Deputy Member | 0 companies |
| Jose Adam Juhani Kautonen | Deputy auditor | 0 companies |
| Juha Kalevi Heino | Chief Executive Officer | 0 companies |
| Kiri Kasperi Sopanen | Audit | 0 companies |